These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8000928)

  • 1. Monitoring and preventive care of the paralyzed patient in respiratory failure.
    Dulin PG; Williams CJ
    Crit Care Clin; 1994 Oct; 10(4):815-29. PubMed ID: 8000928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular blocking agents in the management of respiratory failure. Indications and treatment guidelines.
    Sapirstein A; Hurford WE
    Crit Care Clin; 1994 Oct; 10(4):831-43. PubMed ID: 8000929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
    Kleinpell R; Bedrosian C; McCormick L; Kremer M; Bujalski L; Bronsted R
    Am J Crit Care; 1996 Nov; 5(6):449-54. PubMed ID: 8922161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blockade in adult intensive care.
    Topulos GP
    New Horiz; 1993 Aug; 1(3):447-62. PubMed ID: 7922424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agreement between muscle movement and peripheral nerve stimulation in critically ill pediatric patients receiving neuromuscular blocking agents.
    Peña O; Prestjohn S; Guzzetta CE
    Heart Lung; 2000; 29(5):309-18. PubMed ID: 10986525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of pharmacologically induced neuromuscular blockade using peripheral nerve stimulation.
    Loyola R; Dreher HM
    Dimens Crit Care Nurs; 2003; 22(4):157-64; quiz 165-6. PubMed ID: 12893991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring neuromuscular blockade in the intensive care unit: the peripheral nerve stimulator.
    Rowlee SC
    Heart Lung; 1999; 28(5):352-62; quiz 363-4. PubMed ID: 10486453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
    Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
    Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring neuromuscular blockade in the adult ICU.
    Ford EV
    Am J Crit Care; 1995 Mar; 4(2):122-30; quiz 131-2. PubMed ID: 7749444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular blockade: indications, peripheral nerve stimulation, and other concurrent interventions.
    Davidson JE
    New Horiz; 1994 Feb; 2(1):75-84. PubMed ID: 7922432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical and interpretive problems of peripheral nerve stimulation in monitoring neuromuscular blockade in the intensive care unit.
    Rudis MI; Guslits BG; Zarowitz BJ
    Ann Pharmacother; 1996 Feb; 30(2):165-72. PubMed ID: 8835051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulnar peripheral nerve stimulation by train-of-four technique in adult nonmedicated patients.
    Davidson JE; Verderber A; Lake V; Weinger M; Partridge B; Munden B; Taylor J
    Am J Crit Care; 1994 Jul; 3(4):273-5. PubMed ID: 7920955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral electrical stimulation: titrating neuromuscular blocking agent levels.
    Hill L
    Dimens Crit Care Nurs; 1995; 14(6):305-14. PubMed ID: 8631213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sedation and neuromuscular blockade in patients with acute respiratory failure.
    Luer JM
    Crit Care Nurse; 2002 Oct; 22(5):70-5. PubMed ID: 12382619
    [No Abstract]   [Full Text] [Related]  

  • 15. A national survey of critical care nurses' practices related to administration of neuromuscular blocking agents.
    Foster JG; Kish SK; Keenan CH
    Am J Crit Care; 2001 May; 10(3):139-45. PubMed ID: 11340735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.
    Rhoney DH; Murry KR
    J Intensive Care Med; 2003; 18(3):139-45. PubMed ID: 14984632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [-Atypical pseudocholinesterase and clinical error with train-of-four visual monitoring].
    Fraile JR; Gutiérrez A; Bermejo L; Ferrando A; Quirós P
    Rev Esp Anestesiol Reanim; 1996 Jan; 43(1):45-6. PubMed ID: 8851840
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of neuromuscular blockade in the critically ill patient.
    Burry L; HoSang M; Hynes-Gay P
    Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate monitoring of neuromuscular blockade using a peripheral nerve stimulator--a review.
    Beemer GH; Reeves JH; Bjorksten AR
    Anaesth Intensive Care; 1990 Nov; 18(4):490-6. PubMed ID: 2268016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedation and neuromuscular blockade in patients with acute respiratory failure.
    Luer JM
    Crit Care Nurse; 2000 Oct; 20(5):84-9. PubMed ID: 11878492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.